Literature DB >> 26941959

Understanding inherited genetic risk of adult glioma - a review.

Terri Rice1, Daniel H Lachance1, Annette M Molinaro1, Jeanette E Eckel-Passow1, Kyle M Walsh1, Jill Barnholtz-Sloan1, Quinn T Ostrom1, Stephen S Francis1, Joseph Wiemels1, Robert B Jenkins1, John K Wiencke1, Margaret R Wrensch1.   

Abstract

During the past six years, researchers have made major progress identifying common inherited genetic variation that increases risk for primary adult glioma. This paper summarizes knowledge about rare familial cancer syndromes that include adult glioma and reviews the available literature on the more recently discovered common inherited variation. Ten independent inherited variants in eight chromosomal regions have been convincingly associated with increased risk for adult glioma. Most of these variants increase relative risk of primary adult glioma by 20% to 40%, but the TP53 variant rs78378222 confers a two-fold relative risk (ie, 200%), and rs557505857 on chromosome 8 confers a six-fold relative risk of IDH-mutated astrocytomas and oligodendroglial tumors (ie, 600%). Even with a six-fold relative risk, the overall risk of developing adult glioma is too low for screening for the high-risk variant on chromosome 8. Future studies will help clarify which inherited adult glioma risk variants are associated with subtypes defined by histology and/or acquired tumor mutations. This review also provides an information sheet for primary adult glioma patients and their families.

Entities:  

Keywords:  epidemiology; genetics; primary adult glioma; risk; variants

Year:  2015        PMID: 26941959      PMCID: PMC4774334          DOI: 10.1093/nop/npv026

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  33 in total

1.  Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.

Authors:  Marianne Labussière; Blandine Boisselier; Karima Mokhtari; Anna-Luisa Di Stefano; Anais Rahimian; Marta Rossetto; Pietro Ciccarino; Olivier Saulnier; Rosina Paterra; Yannick Marie; Gaetano Finocchiaro; Marc Sanson
Journal:  Neurology       Date:  2014-08-22       Impact factor: 9.910

2.  Rare variants in TP53 and susceptibility to neuroblastoma.

Authors:  Sharon J Diskin; Mario Capasso; Maura Diamond; Derek A Oldridge; Karina Conkrite; Kristopher R Bosse; Mike R Russell; Achille Iolascon; Hakon Hakonarson; Marcella Devoto; John M Maris
Journal:  J Natl Cancer Inst       Date:  2014-03-14       Impact factor: 13.506

3.  A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.

Authors:  Simon N Stacey; Patrick Sulem; Aslaug Jonasdottir; Gisli Masson; Julius Gudmundsson; Daniel F Gudbjartsson; Olafur T Magnusson; Sigurjon A Gudjonsson; Bardur Sigurgeirsson; Kristin Thorisdottir; Rafn Ragnarsson; Kristrun R Benediktsdottir; Bjørn A Nexø; Anne Tjønneland; Kim Overvad; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Kari Hemminki; Cristina Corredera; Victoria Fuentelsaz; Pilar Grasa; Sebastian Navarrete; Fernando Fuertes; Maria D García-Prats; Enrique Sanambrosio; Angeles Panadero; Ana De Juan; Almudena Garcia; Fernando Rivera; Dolores Planelles; Virtudes Soriano; Celia Requena; Katja K Aben; Michelle M van Rossum; Ruben G H M Cremers; Inge M van Oort; Dick-Johan van Spronsen; Jack A Schalken; Wilbert H M Peters; Brian T Helfand; Jenny L Donovan; Freddie C Hamdy; Daniel Badescu; Ovidiu Codreanu; Mariana Jinga; Irma E Csiki; Vali Constantinescu; Paula Badea; Ioan N Mates; Daniela E Dinu; Adrian Constantin; Dana Mates; Sjofn Kristjansdottir; Bjarni A Agnarsson; Eirikur Jonsson; Rosa B Barkardottir; Gudmundur V Einarsson; Fridbjorn Sigurdsson; Pall H Moller; Tryggvi Stefansson; Trausti Valdimarsson; Oskar T Johannsson; Helgi Sigurdsson; Thorvaldur Jonsson; Jon G Jonasson; Laufey Tryggvadottir; Terri Rice; Helen M Hansen; Yuanyuan Xiao; Daniel H Lachance; Brian Patrick O Neill; Matthew L Kosel; Paul A Decker; Gudmar Thorleifsson; Hrefna Johannsdottir; Hafdis T Helgadottir; Asgeir Sigurdsson; Valgerdur Steinthorsdottir; Annika Lindblom; Robert S Sandler; Temitope O Keku; Karina Banasik; Torben Jørgensen; Daniel R Witte; Torben Hansen; Oluf Pedersen; Viorel Jinga; David E Neal; William J Catalona; Margaret Wrensch; John Wiencke; Robert B Jenkins; Eduardo Nagore; Ulla Vogel; Lambertus A Kiemeney; Rajiv Kumar; José I Mayordomo; Jon H Olafsson; Augustine Kong; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2011-09-25       Impact factor: 38.330

Review 4.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

5.  Chromosome 7p11.2 (EGFR) variation influences glioma risk.

Authors:  Marc Sanson; Fay J Hosking; Sanjay Shete; Diana Zelenika; Sara E Dobbins; Yussanne Ma; Victor Enciso-Mora; Ahmed Idbaih; Jean-Yves Delattre; Khe Hoang-Xuan; Yannick Marie; Blandine Boisselier; Catherine Carpentier; Xiao-Wei Wang; Anna Luisa Di Stefano; Marianne Labussière; Konstantinos Gousias; Johannes Schramm; Anne Boland; Doris Lechner; Ivo Gut; Georgina Armstrong; Yanhong Liu; Robert Yu; Ching Lau; Maria Chiara Di Bernardo; Lindsay B Robertson; Kenneth Muir; Sarah Hepworth; Anthony Swerdlow; Minouk J Schoemaker; H-Erich Wichmann; Martina Müller; Stefan Schreiber; Andre Franke; Susanne Moebus; Lewin Eisele; Asta Försti; Kari Hemminki; Mark Lathrop; Melissa Bondy; Richard S Houlston; Matthias Simon
Journal:  Hum Mol Genet       Date:  2011-04-29       Impact factor: 6.150

6.  Genome-wide association study identifies five susceptibility loci for glioma.

Authors:  Sanjay Shete; Fay J Hosking; Lindsay B Robertson; Sara E Dobbins; Marc Sanson; Beatrice Malmer; Matthias Simon; Yannick Marie; Blandine Boisselier; Jean-Yves Delattre; Khe Hoang-Xuan; Soufiane El Hallani; Ahmed Idbaih; Diana Zelenika; Ulrika Andersson; Roger Henriksson; A Tommy Bergenheim; Maria Feychting; Stefan Lönn; Anders Ahlbom; Johannes Schramm; Michael Linnebank; Kari Hemminki; Rajiv Kumar; Sarah J Hepworth; Amy Price; Georgina Armstrong; Yanhong Liu; Xiangjun Gu; Robert Yu; Ching Lau; Minouk Schoemaker; Kenneth Muir; Anthony Swerdlow; Mark Lathrop; Melissa Bondy; Richard S Houlston
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

7.  The 8q24 gene desert: an oasis of non-coding transcriptional activity.

Authors:  Konrad Huppi; Jason J Pitt; Brady M Wahlberg; Natasha J Caplen
Journal:  Front Genet       Date:  2012-04-30       Impact factor: 4.599

8.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations.

Authors:  Danielle Welter; Jacqueline MacArthur; Joannella Morales; Tony Burdett; Peggy Hall; Heather Junkins; Alan Klemm; Paul Flicek; Teri Manolio; Lucia Hindorff; Helen Parkinson
Journal:  Nucleic Acids Res       Date:  2013-12-06       Impact factor: 16.971

9.  TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.

Authors:  M Labussière; A L Di Stefano; V Gleize; B Boisselier; M Giry; S Mangesius; A Bruno; R Paterra; Y Marie; A Rahimian; G Finocchiaro; R S Houlston; K Hoang-Xuan; A Idbaih; J-Y Delattre; K Mokhtari; M Sanson
Journal:  Br J Cancer       Date:  2014-10-14       Impact factor: 7.640

10.  Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222.

Authors:  V Enciso-Mora; F J Hosking; A L Di Stefano; D Zelenika; S Shete; P Broderick; A Idbaih; J-Y Delattre; K Hoang-Xuan; Y Marie; M Labussière; A Alentorn; P Ciccarino; M Rossetto; G Armstrong; Y Liu; K Gousias; J Schramm; C Lau; S J Hepworth; M Schoemaker; K Strauch; M Müller-Nurasyid; S Schreiber; A Franke; S Moebus; L Eisele; A Swerdlow; M Simon; M Bondy; M Lathrop; M Sanson; R S Houlston
Journal:  Br J Cancer       Date:  2013-04-09       Impact factor: 7.640

View more
  33 in total

Review 1.  Genetic and molecular epidemiology of adult diffuse glioma.

Authors:  Annette M Molinaro; Jennie W Taylor; John K Wiencke; Margaret R Wrensch
Journal:  Nat Rev Neurol       Date:  2019-06-21       Impact factor: 42.937

2.  Older age at the completion of linear growth is associated with an increased risk of adult glioma.

Authors:  Rebecca B Little; L Burt Nabors; Jeffrey J Olson; Zachary J Thompson; Carrie M Rozmeski; Renato V LaRocca; Peter A Forsyth; Reid C Thompson; Robert A Oster; Sajeel A Chowdhary; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2017-03-04       Impact factor: 2.506

Review 3.  Management of diffuse low-grade gliomas in adults - use of molecular diagnostics.

Authors:  Jan Buckner; Caterina Giannini; Jeanette Eckel-Passow; Daniel Lachance; Ian Parney; Nadia Laack; Robert Jenkins
Journal:  Nat Rev Neurol       Date:  2017-05-12       Impact factor: 42.937

4.  Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus.

Authors:  David Schiff; Martin Van den Bent; Michael A Vogelbaum; Wolfgang Wick; C Ryan Miller; Martin Taphoorn; Whitney Pope; Paul D Brown; Michael Platten; Rakesh Jalali; Terri Armstrong; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

Review 5.  Inherited genetics of adult diffuse glioma and polygenic risk scores-a review.

Authors:  Jeanette E Eckel-Passow; Daniel H Lachance; Paul A Decker; Thomas M Kollmeyer; Matthew L Kosel; Kristen L Drucker; Susan Slager; Margaret Wrensch; W Oliver Tobin; Robert B Jenkins
Journal:  Neurooncol Pract       Date:  2022-03-12

6.  Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.

Authors:  Josie Hayes; Yao Yu; Llewellyn E Jalbert; Tali Mazor; Lindsey E Jones; Matthew D Wood; Kyle M Walsh; Henrik Bengtsson; Chibo Hong; Stefan Oberndorfer; Thomas Roetzer; Ivan V Smirnov; Jennifer L Clarke; Manish K Aghi; Susan M Chang; Sarah J Nelson; Adelheid Woehrer; Joanna J Phillips; David A Solomon; Joseph F Costello
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 12.300

7.  Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients.

Authors:  Tao Zhu; Pan Xie; Yuan-Feng Gao; Ma-Sha Huang; Xi Li; Wei Zhang; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  CNS Neurosci Ther       Date:  2018-01-15       Impact factor: 5.243

8.  Genome-wide analysis of high-risk primary brain cancer pedigrees identifies PDXDC1 as a candidate brain cancer predisposition gene.

Authors:  Lisa A Cannon-Albright; James M Farnham; Jeffrey Stevens; Craig C Teerlink; Cheryl A Palmer; Kerry Rowe; Melissa H Cessna; Deborah T Blumenthal
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

9.  Prospective investigation of polyomavirus infection and the risk of adult glioma.

Authors:  Kathleen M Egan; Youngchul Kim; Noemi Bender; James M Hodge; Anna E Coghill; Stephanie A Smith-Warner; Dana E Rollison; Lauren R Teras; Tom K Grimsrud; Tim Waterboer
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

10.  Toenail selenium, genetic variation in selenoenzymes and risk and outcome in glioma.

Authors:  Noah C Peeri; Jordan H Creed; Gabriella M Anic; Reid C Thompson; Jeffrey J Olson; Renato V LaRocca; Sajeel A Chowdhary; John D Brockman; Travis A Gerke; L Burton Nabors; Kathleen M Egan
Journal:  Cancer Epidemiol       Date:  2018-05-25       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.